Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB
Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB

Burger-Kentischer, Anke Dr.

Head of Innovation Field Cell and Tissue Technologies

Dr. Anke Burger-Kentischer leads the IGB Innovation Field Cell and Tissue Technologies. She obtained her PhD at the University of Tübingen on “Cellular and Molecular Mechanisms of the Radiation induced Lung Fibrosis”. During her Postdoctoral stay at the Institute of Physiology of the Ludwig–Maximilian-University in Munich, she focused on the cell-specific influence of osmotic stress on protein expression in the kidney. Thereafter, she started her work in Stuttgart, alternating between Fraunhofer IGB and the Institute for Interfacial Engineering (IGVT) at the University of Stuttgart.

Expand all Close all

  • The innovation field "Cell and Tissue Technologies" stands for the development and establishment of human in vitro test models for preclinical testing of drugs, determination of e.g. toxicity and allergenicity of cosmetics & chemicals as well as for clinical applications in personalized/precision medicine.

    We develop a wide variety of model systems ranging from simple high throughput cell assays to macroscopic complex 3D tissue models. An overarching focus is on the integration of immune components. Based on this broad range of models, the toxicity of pharmaceutical agents ("small molecules", biopharmaceuticals, gene and cell therapeutics), cosmetic preparations or environmental and industrial chemicals can be tested. In addition to the development of "healthy" tissue structures, another focus is on the generation of disease states in in vitro models. These disease models provide a valuable contribution for the identification of targets, the investigation of drug efficacy and personalized medicine.

  • Professional career
    2019 – current Head of Innovation Field Cell and Tissue Technologies, Fraunhofer IGB Stuttgart
    2015 – 2019 Deputy Head of Department Molecular Biotechnology, Fraunhofer IGB Stuttgart
    1999 – 2019 Group Manager of the Molecular Cell Biology Group within the Department of Molecular Biotechnology at Fraunhofer IGB

    • Fraunhofer Excellence Award 2018

  • Project title Project title long Funding source Period
    Immunsystem-to-go   BMBF June 2022
    TOPAS-COVID19 Wear physiologically optimized protective masks suitable for everyday use BMBF December 2020 – November 2022
    DRECOR Drug REpurposing for CORona" with subproject "Delivery4COVID-19 – Drug delivery systems for drug candidates targeting SARS-CoV-2" Fraunhofer September 2020 – September 2021
    Psoriceptors Validation of innate immune receptors as targets for the treatment of psoriasis BMBF May 2020 – April 2022
    ISE-CoV-2-Screen Test systems for the identification of specific anti-corona molecules Fraunhofer April 2020 – April 2021
    CoSE Corona quick test for self-application BMBF April 2020 – April 2021
    imSAVAR Immune Safety Avatar: Nonclinical mimicking of the immune system effects of immunomodulatory therapies EU December 2019  – November 2025
    PsoBiBi Development of psoriasis therapeutics using bicyclic genetically encoded libraries BMWi November 2019 – October 2022
     Fraunhofer Lighthouse Project "Cell-free Bioproduction" Cell-free bioproduction with integrated energy supply BMBF, Fraunhofer March 2011 - August 2014